TITLE:
Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score (GARS) with electrotherapy a paradigm shift in pain treatment programs
AUTHORS:
Kenneth Blum, David Han, Marlene Oscar-Berman, Gary Reinl, Nicholas DiNubile, Margaret A. Madigan, Anish Bajaj, Bernard William Downs, John Giordano, Wayne Westcott, Leonard Smith, Eric R. Braverman, Kristina Dushaj, Mary Hauser, Thomas Simpatico, Thomas McLaughlin, Joan Borsten, Debmayla Barh
KEYWORDS:
Microcirculation; Angiogenesis; Analgesic Therapy; Electrical Device Stimulation; Tissue Loading; Remodeling; Genetic Addiction Risk Score (GARS); Reward Deficiency Syndrome (RDS)
JOURNAL NAME:
Health,
Vol.5 No.11A,
November
13,
2013
ABSTRACT: The mounting endemic of prescription iatrogenic opioid dependence in pain patients provoked this treatise about an alternative method that can be used to treat pain, improve function and reduce the risk of opioid dependence. It is well known that as well as the side effects reported for chronic opioid therapy, genetically predisposed individuals are at risk for opioid dependence. We propose the use of the Genetic Addiction Risk Score (GARS) assessment to identify patients early in treatment who should avoid narcotic pain medications. Primarily, this review will be an exploration of the mechanisms of action of an electrotherapeutic alternative to narcotic treatment that can be used to augment tissue healing and reduce the pain associated with human injuries and neuropathies. This particular electrotherapeutic device was developed at the Electronic Waveform Laboratory in Huntington Beach, California and is called the H-Wave? device. The primary effect of the H-Wave?device is stimulation (HWDS) of small diameter fibers of “red-slow-twitch” skeletal muscle. Mechanisms of action of HWDS have been investigated in both animal and human studies. They include edema reduction, induction of nitric oxide dependent augmented microcirculation and angiogenesis, small muscle contraction that eliminates transcapillary fluid shifts, reducing the painful effects of tetanizing fatigue and gradual loading of healing injured muscle tissue that helps repair and remodeling. A recent metaanalysis found a moderate-to-strong-positive effect of the HWDS in providing pain relief, reducing the requirement for pain medication, with the most robust effect being increased functionality. We are proposing that GARS can be used to identify those at risk of developing opioid dependence and that the need for opioid analgesia can be reduced by use of this electro therapeutic alternative to opioid analgesia in the treatment of pain and injuries.